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ABSTRACT: AMPK is a critical energy sensor and target for widely used antidiabetic drugs. In b cells, elevated glucose
concentrations lower AMPK activity, and the ablation of both catalytic subunits [b-cell–specific AMPK double-
knockout (bAMPKdKO) mice] impairs insulin secretion in vivo and b-cell identity. MicroRNAs (miRNAs) are small
RNAs that silence gene expression that are essential for pancreaticb-cell function and identity and altered in diabetes.
Here,wehaveexploredthemiRNAsactingdownstreamofAMPKinmouseandhumanb cells.Weidentified14down-
regulated and 9up-regulatedmiRNAs inbAMPKdKOvs. control islets.Geneontology analysis of targeted transcripts
revealed enrichment in pathways important for b-cell function and identity. The most down-regulated miRNA was
miR-184 (miR-184-3p), an important regulator of b-cell function and compensatory expansion that is controlled by
glucose and reduced in diabetes. We demonstrate that AMPK is a potent regulator and an important mediator of the
negativeeffectsofglucoseonmiR-184expression.Additionally,wereveal sexualdimorphisminmiR-184expression in
mouse and human islets. Collectively, these data demonstrate that glucose-mediated changes in AMPK activity are
central for the regulation of miR-184 and other miRNAs in islets and provide a link between energy status and gene
expression in b cells.—Martinez-Sanchez, A., Nguyen-Tu, M.-S., Cebola, I., Yavari, A., Marchetti, P., Piemonti, L., de
Koning, E., Shapiro, A.M. J., Johnson, P., Sakamoto, K., Smith, D.M., Leclerc, I., Ashrafian, H., Ferrer, J., Rutter, G. A.
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Elevated blood glucose concentrations stimulate in-
sulin secretion from the b cell but, in the long term, can
lead to b-cell dysfunction and loss of b-cell identity,
contributing to the development of type 2 diabetes (T2D)
(1). AMPK is a fuel-sensitive enzyme involved in the
control of whole-body glucose homeostasis and is a
potential target for the treatment of T2D (2, 3). AMPK
activation induces glucose uptake and utilization by
peripheral tissues, especially skeletal muscle, and has
been suggested to mediate the beneficial effects of ex-
ercise and of some antidiabetic drugs (2). In the b cell,
AMPK is activated by glucose deprivation and may
inhibit insulin secretion (4, 5). Recent studies (2, 3)
suggest that chronic activation of AMPK may also im-
pair insulin secretion.
Our group has recently generated two knockout mod-
els with b-cell–specific deletion of AMPK catalytic sub-
units a1 and a2 (bAMPKdKO, b-cell–specific AMPK
double-knockout) or the main AMPK-upstream kinase
liver kinase B1 (LKB1) (bLKB1KO, b-cell–specific LKB1
knockout) (6). bAMPKdKO and bLKB1KO islets showed
increased glucose-stimulated insulin secretion in vitro,
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although gene inactivation only resulted in increased in-
sulin secretion in vivo in thebLBK1KOanimals.Moreover,
both bAMPKdKO and bLKB1KO islets displayed a
strong, but only partially overlapping, alteration of gene
expression and thus impaired b-cell identity. Corre-
spondingly, both bLKB1KO and bAMPKdKO islets
displayed modified expression of several T2D-
associated and T2D-regulated genes and increased ex-
pression of neuronal genes (6). These results suggest
that chronic inhibition of AMPK might aggravate dis-
ease progression. However, the downstream targets
and the underlyingmechanism of AMPK action in theb
cell remain largely unknown.
MicroRNAs (miRNAs) are 18–22 nt noncoding RNAs
that play a critical role in the regulation of most biological
processes and are implicated in the establishment and
development of multiple diseases. miRNAs are generally
transcribed by Pol II polymerase as longer primary tran-
scripts that are quickly processed in the nucleus to gen-
erate ;70–80 nt–long hairpin RNAs called premiRNAs.
PremiRNAs are exported to the cytosol, where further
processing generates thematuremiRNAs thatwill induce
translational silencing and/or degradation of the target
mRNAs (7).
miRNAs are essential for the maturation of all en-
docrine populations (8, 9) and formatureb-cell function
(10, 11). Specific miRNAs have been linked to processes
associated with T2D, such as apoptosis, response to
cytokines, or insulin secretion (12).Moreover, ourwork
(11) and that of others (9, 10) supports the view that
miRNAs are enforcers of b-cell identity (12, 13) and that
their expression is altered in diabetes (12, 14). In re-
sponse to insulin resistance, chronic increases in blood
glucose levels are believed to contribute to the failure in
b-cell function (15). Consistentwith thismodel, glucose
affects miRNA expression in b cells (12, 16). Other nu-
tritional and environmental factors also alter the islet
miRNome (12).
MiR-184 (miR-184-3p) has been identified as an im-
portant modulator of compensatory b-cell expansion
during insulin resistance in the face of obesity (14, 17) and
pregnancy (17) and is altered indiabeticmice andhumans
(14, 17). In mouse islets, miR-184 expression is down-
regulated by glucose and palmitate in vitro (14, 18) and is
strongly up-regulated by feeding with a ketogenic diet
(18). Nevertheless, at present, the intracellular signaling
pathways underlying the regulation of this and other
b-cell miRNAs are largely unknown.
Here, we identified 23 miRNAs [Benjamini-Hochberg
adjusted P value for false discovery rate (FDR) , 0.15]
whose expression is altered in islets after b-cell–specific
deletion of AMPK. Many of these miRNAs are predicted
to control several processes important for b-cell func-
tion and identity. Moreover, we demonstrate that
AMPK is a potent regulator of miR-184 expression in
mouse and human islets and unveil a sexual dimorphism
on miR-184 expression. Finally, we demonstrate that
AMPK is required forglucose-dependentdown-regulation
of miR-184 in vitro and in vivo, providing a much sought-
after link between themetabolic environment andmiRNA
expression in b cells.
MATERIALS AND METHODS
Generation and maintenance of transgenic mice
bAMPKdKO (AMPKa1fl/fl, AMPKa2fl/fl, Ins1-Cre+/2), control
(AMPKa1fl/fl, AMPKa2fl/fl, Ins1-Cre2/2), bLKB1KO (LKB1fl/fl,
Ins1-Cre+/2), control (LKB1fl/fl, Ins1-Cre2/2), and R299Q g2
AMPK knock-in mice carrying 1 (heterozygous) or two (homo-
zygous)mutant alleleswerepreviouslygeneratedandmaintained
as described previously (3, 6) with free access to standard mouse
chowdietorketogenicdiet (Ssniff, Soest,Germany).Glycemiawas
measured using tail vein blood and an AccuCheck Aviva gluc-
ometer (Roche, Basel, Switzerland). All in vivo procedures were
approved by the UK Home Office Animal Scientific Procedures
Act, 1986 (Licenses PPL 70/7349 and PA03F7F0F to I.L.).
Isolation and maintenance of islets and cell lines
Mouse islets were isolated by digestion with collagenase as
previously described (11) and, unless otherwise indicated, were
allowed to recover from digestion overnight in culture medium
[RPMI 1640, 10% fetal bovine serum (FBS), L-glutamine, and
11 mM glucose]. Human islets were maintained in RPMI 1640,
10% FBS, L-glutamine, and 5.5 mM glucose unless otherwise in-
dicated. Donor characteristics of human islets are presented in
Table 1. MIN6 cells were grown in high-glucose DMEM, 15%
FBS, and L-glutamine.
AMPK activation was performed with 20 mM compound 13
(C13) (19) plus 50mMcompound 991 (C991) (20) inMIN6 cells or
human islets for 14 or 24 h, respectively.
RNA extraction, reverse transcription, and
quantitative PCR
RNA, including miRNAs, was extracted using Trizol (Thermo
Fisher Scientific, Waltham, MA, USA) following the manufac-
turer’s instructions.
MiRNAdetection using quantitative PCR (qPCR) panels was
conducted at Exiqon Services (Vedbaek, Denmark). Fifty nano-
grams RNA was reverse transcribed with the miRcury LNA
Universal RTmiRNAKit (Exiqon). cDNAwas assayed using the
mouse and rat panel I + II and ExiLent SYBR Green master mix
(Exiqon) in a LightCycler 480 System (Roche). Results were an-
alyzed using Roche LC Software. Melting curves and melting
temperature were confirmed for quality control, and only assays
with 5Cq less than thenegative control andCq,37were included
in the analysis. The average of assays detected in all sampleswas
used as normalizer (averageCq), determinedbyNormFinder (21)
as the most stable normalizer [normalized Cq = average Cq 2
assayCq (sample)]. Student’s t testwas performed for each assay,
and raw P values and P values adjusted for multiple testing by
the Benjamini-Hochberg correction (Padj) are reported. Un-
supervised hierarchical clustering and principal component
analysis (PCA) were performed with the normalized Cq values.
Fold change between control and bAMPKdKO islets was de-
termined by the ΔΔCt method.
Individual miRNA RT-qPCR assays were performed as de-
scribed above from 30 ng RNA in a 7900HT Fast Real-Time PCR
System (ThermoFisher Scientific).miR-7d-3pwas identified as the
miRNA with the least variability in the panel assays (using
NormFinder)andwas thereforechosenas theendogenouscontrol.
RT-qPCR for protein-coding mRNAs and pri-miR-184 were
performed as previously described (11). For pri-miR-184, the
random primers were substituted by an anchored oligo dT
primer (Thermo Fisher Scientific, Paisley, UK) in the reverse
transcription reaction.
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Gene target and gene ontology analysis
TargetScanMouse (release 7.1) (22) was used to identify miRNA
target genes. Tables containing prediction scores were merged
with those containing gene fold change values in bAMPKdKO
islets (6) using RStudio. Cytoscape (23) was used to visualize
miRNAs and predicted targets. EnrichR (24) was used for gene
ontology (GO) enrichment analysis, and REVIGO (25) was used
to summarize and visualize enrichedGO termswithPadj, 0.05.
Immunoblot and immunohistochemistry
Slides were prepared from isolated pancreata and visualized as
previously detailed (11). ImageJ software was used to calculate
themean intensityonphospho-AMPKThr172 in theb-cell areaand
in the acinar tissue surrounding the islets. Western blotting was
performed as previously described (11) with 100–150 human
or mouse islets. Anti–acetyl-CoA-carboxylase (ACC), anti-
phospho-ACC, anti-AMPK, anti–phospho-AMPK Thr 172,
anti-Raptor, and anti–phospho-Raptorwere fromCell Signaling
Technology (Danvers, MA, USA). Anti-glucagon was from
Sigma-Aldrich (St. Louis, MO, USA).
Statistical analysis
Statistical significance was evaluated with GraphPad Prism 7.0
software (GraphPad, La Jolla, CA,USA) as indicated in the figure
legends. All data are shown as means 6 SEM. Unless otherwise
indicated, P, 0.05 was considered statistically significant.
RESULTS
AMPK regulates miRNAs involved in pathways
relevant for b-cell function
To identify miRNAs regulated by AMPK in the b cell, we
performed miRNA profiling on islets from mice with
b-cell–specific deletionof both catalytic subunits ofAMPK
TABLE 1. Donor characteristics of human islets as provided by the isolation center
Identiﬁer Body mass index (kg/m2) Age Origin facility
Male
P49a 23.6 55 Edmonton, AB, Canada (McDonald)
P59 21.5 68 Pisa, Italy
P60 27.8 61 Milan, Italy
P66 31 52 Pisa, Italy
P74 24.5 83 Pisa, Italy
P76 22.9 75 Pisa, Italy
P80 35 54 Edmonton, AB, Canada (McDonald)
P81 29.7 65 Edmonton, AB, Canada (McDonald)
P84 NS 89 Pisa, Italy
P86 23 41 Leiden, The Netherlands
P89 24.5 64 Pisa, Italy
P94 29.4 51 Edmonton, AB, Canada (McDonald)
P97 28.7 62 Edmonton, AB, Canada (Shapiro)
P100 32.6 42 Pisa, Italy
P101a 35 57 Leiden, The Netherlands
P112 28.8 69 Edmonton, AB, Canada (McDonald)
P115 30.5 27 Edmonton, AB, Canada (Shapiro)
P124 22.9 18 Edmonton, AB, Canada (Shapiro)
P125 24.5 75 Pisa, Italy
P127a 32 57 Oxford, United Kingdom
P128 22.5 74 Pisa, Italy
P119 29.4 49 Edmonton, AB, Canada (Shapiro)
Female
P58 21.7 68 Edmonton, AB, Canada (McDonald)
P77 33.1 66 Edmonton, AB, Canada (McDonald)
P78a 30.6 54 Edmonton, AB, Canada (McDonald)
P85 23.9 62 Pisa, Italy
P87 23 66 Pisa, Italy
P91a 21 53 Leiden, The Netherlands
P93 26 57 Milan, Italy
P102 31.5 78 Edmonton, AB, Canada (Shapiro)
P106 20.6 49 Milan, Italy
P113 32.3 30 Edmonton, AB, Canada (McDonald)
P114 35 46 Oxford, United Kingdom
P116 26 55 Milan, Italy
P117 24.5 52 Milan, Italy
P120 25.8 58 Pisa, Italy
P123 22 88 Pisa, Italy
P126 NS NS Edmonton, AB, Canada (McDonald)
aDonors diagnosed with T2D.
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(bAMPKdKO) vs. controls .RNAwas extracted from islets
from 3 bAMPKdKO and 3 control animals and analyzed
by Exiqon using qPCR panels. These allow the simulta-
neous detection of 752 mature miRNAs. Of those, an av-
erage of 376 miRNAs were detected per sample, and 323
were detected in all samples.
Unsupervised hierarchical clustering (Fig. 1A) and
principal component analysis (PCA) (Fig. 1B) revealed
that, as anticipated, control and bAMPKdKO samples
clustered together. With a cutoff value of P , 0.05 (Stu-
dent’s t test), 81 miRNAs were found to be differentially
expressed in bAMPKdKO vs. control islets (Supplemental
Table 1). After Benjamini-Hochberg correction (FDR ,
0.15), 13 and 9 miRNAs were down- and up-regulated,
respectively (Supplemental Table 1 and Table 2). We also
noticed that the miRNA that was most differentially
expressed,miR-184-3p (miR-184),wasundetectable in one
of the bAMPKdKO samples, and therefore the statistical
significance of its change was not evaluated initially
(Supplemental Table 1 and Table 2).
To further understand the contribution of the affected
miRNAs to AMPK function, we used TargetScan (22) to
identify predicted targets of miRNAs, which showed a
.2-fold change in bAMPKdKO vs. control islets [down-
regulated miRNAs (DownmiRs): miR-184, miR-34bc-5p,
miR-34b-3p, miR-96-5p, miR-378a-3p, miR-31-3p, miR-
670-5p; up-regulated miRNAs: miR-335-5p, miR-135a-5p,
miR-125b-5p plus miR-100-5p, with a fold change of 1.88
but a Padj ,0.05). The effect of b-cell–specific AMPK de-
letion on the expression of these miRNAs was further
validated in islets isolated from a higher number of ani-
mals (Fig. 1C). Let-7d-3p expressionwas highly stable (i.e.,
similar between different samples) according to the panel
assays and was therefore used as endogenous control.
Comparable results were obtained upon normalization
with a second endogenous control, miR-574-3p (data not
shown). Because miRNAs act by silencing gene expres-
sion, we expect an inverse correlation between the ex-
pression of a miRNA and its targets. Thus, using our
previously publishedRNA-seqdata (6),we found that 576
predicted DownmiR targets [TargetScan score (cumula-
tive weighted context score) , 20.1] were significantly
(Padj , 0.1) up-regulated .1.25 fold (UpTargets, Fig. 2A
and Supplemental Table 2] inbAMPKdKO islets,whereas
277 predicted targets of up-regulated miRNAs were
down-regulated (DownTargets, Fig. 2B andSupplemental
Table 3). GO analysis (24, 26) was performed on these
predicted targets (UpTargets and DownTargets in-
dependently) and revealed enrichment (Padj, 0.05) in 37
(Supplemental Table 4) biologic processes for UpTargets.
DownTargets were not involved in biological processes
that passed the Padj threshold, although they might con-
tribute to regulation of ERK1 and ERK2 cascades (Padj =
0.084). We submitted our list of enriched GO terms to
REVIGO (25), which allows summarization and visuali-
zation of long lists of GO terms (Fig. 2C).
Predicted targets (UpTargets) of DownmiRs were
enriched in pathways important for b-cell function,
including adherens junctions and extracellular matrix
organization, angiogenesis, vesicle fusion, calcium-
dependent exocytosis, and nervous system development
(Fig. 2C and Supplemental Table 4). We have previously
reported (6) that bAMPKdKO islets present with altered
secretory function and up-regulation of genes involved in
neuronal function. Thus, our results suggest that the
identified miRNAs are important contributors to AMPK
action in b cells.
AMPK is both necessary and sufficient for
miR-184 expression in mice and humans
As mentioned above, miRNAs down-regulated in
bAMPKdKO islets might be involved in several AMPK-
regulated biologic processes. Moreover, the most down-
regulated miRNA, miR-184, has been demonstrated to
be an important regulator of b-cell proliferation during
compensation after insulin resistance in mice (14, 17).
miR-34b-5p/c-5p (miR-34b/c) was also strongly down-
regulated in bAMPKdKO islets. Although the functions
ofmiR-34b/c are unknown in islets, thesemiRNAs share
seed region sequence (and therefore many predicted
targets) with the third member of the family, miR-34a, a
mediator of compensatoryb-cell expansion, lipotoxicity,
and apoptosis (12). In addition, miR-96-5p (miR-96)
regulates insulin exocytosis in a murine b-cell line (12).
Thus, the latter miRNAs were chosen for further study.
To determine if forced activation of AMPK induces the
expression of these miRNAs and if this regulatory mech-
anism is conserved in human islets, we activated AMPK
pharmacologically using two synergistic small, highly
specific AMPK activators, C991 (20) and C13 (19). As
expected, treatment of human isletswith the activators (20
mM C13 plus 50 mM C991) for 24 h resulted in increased
phosphorylation of AMPK and its well-characterized tar-
gets ACC and Raptor (Fig. 3A). Concomitantly, miR-184
was significantly up-regulated (Fig. 3B), although no sig-
nificant changes were observed in the expression of miR-
34b/c, miR-34b-3p, andmiR-96 (data not shown). Indeed,
miR-34b/c levels, which are low in mouse islets, were
barely detectable in human islets (Fig. 3C), suggesting that
the role of these miRNAs in b cells, if any, might not be
conserved in humans. Correspondingly, overnight treat-
ment of MIN6 b cells with AMPK activators increased
miR-184 expression (Fig. 1A, B).
Further supporting the importance of AMPK in con-
trolling miR-184 expression, islets with b-cell–specific de-
letion of LKB1 (6) displayed reduced miR-184 levels (Fig.
3E). Moreover, islets from mice bearing an activating
mutation of AMPK g2 [R299Q g2 AMPK knock-in mice
(3)] showed elevated miR-184 levels (Fig. 1F).
Together, our results indicate that AMPK is both nec-
essary and sufficient formiR-184 expression inmouse and
human b cells.
miR-184 expression is sex dependent
While performing the experiments described above, we
noticed that islets from control animals contained highly
variable levels of miR-184. Plotting of the values shown in
Fig. 1C according to sex revealed that islets from female
mice express significantly higher levels (.2 fold,P, 0.001)
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Figure 1. AMPK regulates miRNA expression in pancreatic islets. A, B) Heat map and unsupervised hierarchical clustering (A)
and PCA (B) on the 3 control (black, C) and 3 bAMPKdKO (green, KO) samples and top 50 miRNAs with the highest SD. C)
miRNA expression was assessed by RT-qPCR in isolated islets from bAMPKdKO (green) and littermate control (C, black) mice.
Each dot represents islets from a single mouse. Data are expressed as relative to the endogenous control let-7d-3p. *P , 0.05,
***P , 0.001, ****P , 0.0001 (Student’s t test).
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ofmiR-184 vs.male islets (Fig. 4A). To determinewhether
this sex dependence is conserved in humans, we assessed
miR-184 expression in islets from 19 male and 14 female
nondiabetic donors (Table 1). Islets from female donors
expressed higher levels of miR-184 (1.6 fold, P = 0.056,
power of;61% probability of rejecting a null hypothesis)
(Fig. 4B). Levels of other miRNAs were similar in male
and female islets (data not shown).
It has been reported thatmiR-184 is down-regulated
in islets from T2D donors (17). In our study, miR-184
expression was similar in islets from donors with T2D
and healthy donors (Fig. 4C). miR-184 levels tended to
be lower in female patients with T2D vs. control sub-
jects (Fig. 4C, D), whereas this trend was not observed
in male donors.
miR-184 expression did not correlate with age or body
mass index from the donors, whichwas similarwithin the
compared groups (Supplemental Fig. 1 and Table 1).
AMPK mediates the glucose-dependent
regulation of miR-184 in mouse islets
Tattikota et al. (18) have previously reported that miR-
184 is regulated according to glucose metabolism both
in vivo and in vitro. These researchers found that miR-
184 is slightly down-regulated in mouse islets cultured
at high glucose concentrations and is strongly in-
creased in islets from mice starved for .30 h or fed a
low-sugar/ketogenic diet. Nevertheless, the mecha-
nisms underlying this glucose dependency of miR-184
expression have remained unexplored. Given the
strong effect of AMPK on miR-184 expression, we hy-
pothesized that AMPK mediates the effects of glucose
on miR-184.
Treatment of isolated mouse islets with increasing
concentrations of glucose for 48 h led to the dephos-
phorylation of AMPK at Thr-172 as well as its targets
Raptor and ACC (Supplemental Fig. 2A). In inverse
correlation with AMPK activation and consistent with
previously published results (18), miR-184 expression
was slightly but significantly reduced in control islets
incubated at high glucose (Fig. 5A). In contrast,miR-184
expression remained unchanged in bAMPKdKO islets
(Fig. 5A), suggesting that AMPK is required for the
glucose-dependent regulation of miR-184 expression
in vitro. Similarly, treatment of human islets with high
glucose led to dephosphorylation of AMPK and Raptor
(Supplemental Fig. 2B), although ACC phosphoryla-
tion remained unchanged (Supplemental Fig. 2B). Sur-
prisingly, whereas miR-184 expression was decreased
in islets from male donors treated with increasing
glucose concentrations, miR-184 was consistently in-
creased in islets from female donors (Fig. 5B). TXNIP,
which is potently up-regulated at high glucose (27),was
clearly increased (Supplemental Fig. 2C) in both male
and female islets.
Next, we studied the AMPK dependence of the ef-
fects of glucose on miR-184 expression in vivo using
conditions similar to those of Tattikota et al. (18) in our
b-cell–specific bAMPKdKO and bLKB1KO mouse
models. First, control and bLKB1KO animals were
held without food overnight (16 h). Contrary to pub-
lished results (18), miR-184 expression remained
unchanged in unfed vs. fed control animals (Supple-
mental Fig. 3A). Of note, 16 h without food did not
cause obvious changes in AMPK activation (Supple-
mental Fig. 3B, C).
Subsequently, we fed control and knockout animals
a ketogenic (low-carbohydrate) diet that, as antici-
pated, resulted in an early loss ofweight (Supplemental
Fig. 4A) and lowered glycemia (Supplemental Fig. 4B).
In agreementwith Tattikota et al. (18), in our studymiR-
184 was sharply increased in control mice fed a keto-
genic diet (Fig. 5C). By contrast, miR-184 expression in
islets from bAMPKdKO and bLKB1KOmice remained
unchanged (Fig. 5C), confirming thatAMPK is required
for glucose-mediated regulation of isletmiR-184 in vivo.
The fold increase induced by the ketogenic diet was
much higher inmale (3.5-fold) than in female islets (1.6-
fold), with sex-dependent differences in miR-184 ex-
pression eliminated on a ketogenic diet.
MiRNAs are transcribed as primary RNAs of vari-
able length that are processed in a two-step manner
that requires several enzymes and can be regulated at
different levels (7). Expression of miR-184 primary
transcriptwas lower inbAMPKdKO than control islets
(Fig. 6A), suggesting that AMPK regulates miR-184
expression at the transcriptional level. The exact se-
quence of pri-miR-184 and its promoter and regulatory
sequences have not been fully annotated and/or ex-
perimentally validated. Nevertheless, the MIR184
TABLE 2. miRNAs down- and up-regulated in bAMPKdKO vs.
control islets
miRNA Fold change FDR
Down-regulated miRNAs
mmu-miR-184-3p 233.00 N/A
mmu-miR-34c-5p 26.13 0.056
mmu-miR-34b-3p 26.04 0.048
mmu-miR-34b-5p 24.35 0.048
mmu-miR-96-5p 22.68 0.128
mmu-miR-378a-3p 22.16 0.066
mmu-miR-31-3p 22.05 0.128
mmu-miR-670-5p 22.02 0.067
mmu-miR-200a-3p 21.41 0.128
mmu-miR-101a-3p 21.39 0.141
mmu-miR-30e-5p 21.34 0.128
mmu-miR-136-5p 21.34 0.090
mmu-miR-29a-5p 21.32 0.056
mmu-miR-140-5p 21.17 0.128
Up-regulated miRNAs
mmu-miR-9-5p 1.36 0.128
mmu-miR-20a-5p 1.51 0.128
mmu-miR-181a-5p 1.56 0.090
mmu-miR-10b-5p 1.58 0.128
mmu-miR-99a-5p 1.68 0.094
mmu-miR-100-5p 1.88 0.037
mmu-miR-125b-5p 2.20 0.128
mmu-miR-135a-5p 2.57 0.141
mmu-miR-335-5p 4.29 0.057
The average Cq value of all the detected assays was used as nor-
malizer. N/A, not applicable.
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transcription start site might be located up to ;78 kb
upstream of the miRNA loop (28). Our unpublished
assay for transposase-accessible chromatin and sequenc-
ing (ATAC-seq) data (unpublished results) demonstrated
a significant increase in chromatin accessibility in
bLKB1KO islets in two regions located;25 kb (1.3-fold,
P = 0.0074, Padj = 0.08) and;72 kb (1.2-fold, P = 0.0456,
Padj = 0.23) upstream of miR-184 (Fig. 6B). ENCODE
ChIP-seq datasets from liver and CH12 cells show that
the insulator CCCTC-binding factor (CTCF) could bind
at least the most proximal region (Fig. 6B), conserved in
human islets, which could result in repression of miR-
184. Other factors, such as BHLHE40, ETS1, GCN5, or
p300, may bind the most distal region (Fig. 6B).
Figure 2. miRNAs regulated by AMPK are involved in pathways important for b-cell function. A, B) Cytoscape-generated layout of
down-regulated (square, red nodes) (A) and up-regulated (square, green nodes) (B) miRNAs and their predicted targets that are
up-regulated (circle, green nodes) (A) and down-regulated (circle, red nodes) (B), respectively, in bAMPKdKO vs. control islets.
Node size represents the degree of the fold change (the larger, the stronger). The intensity of the gene node color (circles)
indicates the target prediction score according to TargetScan (the darker, the stronger). A full list of miRNA and targets can be
found in Supplemental Tables 2 and 3. C) REViGO Scatterplot of the enriched GO terms. Up-regulated targets of down-
regulated miRNAs (Supplemental Table 2) in bAMPKdKO islets were submitted to EnrichR, which identiﬁed enrichment in 37
(Supplemental Table 4) biologic processes (adjusted P, 0.05). GO terms along with their adjusted signiﬁcance values (P, 0.05)
are represented by circles and are plotted according to semantic similarities with other GO terms. Circle size is proportional to
the frequency of the GO term, and circle color represents the adjusted signiﬁcance value calculated using EnrichR.
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DISCUSSION
Contribution of miRNAs to AMPK signaling in
b cells
The role ofAMPKin theb cell hasbeen stronglydebated in
recent years [reviewed by Fu et al. (29)]. Genetic studies
(3, 4, 6) demonstrate that, paradoxically, AMPK depletion
results in increased glucose-stimulated insulin secretion in
isolated islets aswell as strongly impaired insulin secretion
in vivo. These defects occurred in parallel with changes
in the expression of thousands of mRNAs that suggested
impaired b-cell identity (6). Here, we demonstrate that
AMPK deletion produces changes in the levels of at least
23 islet miRNAs, which are predicted to target ;850
AMPK-regulated mRNAs. Although a limitation of this
Figure 3. AMPK is both necessary and sufﬁcient for miR-184 expression in mouse and human islets. A) Phosphorylation of AMPK at
Thr172 (pAMPK) and its targets Raptor (pRaptor) and ACC (pACC) as well as the total protein (AMPK, Raptor, ACC) was assessed
by Western blotting using speciﬁc antibodies with extracts from human islets (left side panel) or MIN6 cells (right side panel)
treated with AMPK activators C13 (20 mM) and C991 (50 mM) for 24 and 14 h, respectively. P66, P76, and P85 are donor identiﬁers
(see details in Table 1). P66 and P66* correspond to the same donor, but P66* corresponds to islets.100 mm. P66, P76, and P85 islets
were all ,100 mm. B–E) miR-184 expression was assessed by RT-qPCR in human islets (left hand side, n = 5) and MIN6 cells (right
hand side, n = 3) treated with the AMPK activators as in A (B), islets from C57BL/6 mice (upper panel, n = 8–9) and humans without
diabetes (n = 7–9) (C), islets from bLKB1KO (LKB1KO) and littermate control (C, black) mice (D), and islets from R299Q g2 AMPK
knock-in mice [heterozygous (AG2 Het) or homozygous (AG2 Homo) for the mutant allele] and littermate controls (C) (E). In D and
E , each dot represents islets from a single mouse. Data are expressed as relative to the endogenous control let-7d-3p. In panel B, data
are fold-change vs. the untreated sample. **P , 0.01, ***P , 0.001, ****P , 0.0001 (Student’s t test).
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study is that those miRNA–target interactions have not
been experimentally validated, GO analysis of these tar-
gets reveals enrichment in biologic processes that point to
miRNAs as important contributors to AMPK action.
On the top of the list of enriched biologic pathways, we
found angiogenesis, positive regulation of cell migration,
and adherens junction organization. Angiogenesis is es-
sential for islet development and central to the capacity of
the mature islets to sense and fulfill metabolic demands
(30). Likewise, the cell migrationmachinery and adherens
junctions have been proposed to influence b-cell differ-
entiation, survival, and insulin secretion (17, 31).
Impaired b-cell identity
Suggesting impaired identity, neuronal genes were up-
regulated in bAMPKdKO islets (6). MiRNAs have been
described as important regulators of cell fate and efficient
fine-tuners of gene expression (32, 33). Deletion of Dicer
(essential for miRNA maturation) in Ngn31 progenitors
results in dysfunctional adult b cells with up-regulation of
several neuronal genes, such as Rest and Phox2a/b (9). Rest
is up-regulated inbAMPKdKO islets (;1.5-fold) (6) and is
a predicted target of the down-regulated (;2-fold) miR-
670-5pandmiR-200a-3p (1.4-fold). Several other genesup-
regulated in bAMPKdKO islets and predicted targets
of DownmiRs (UpTargets; Supplemental Table 2) are
involved in nervous system development (Supplemental
Table 4), although their role in b cells is unknown.
Other miRNA–target pathways that may contribute to
the loss of b-cell identity after AMPK deletion are the up-
regulated Ldha, a validated target ofmiR-34a/b/c in other
cell types (34, 35), andSox6,which can lowerPdx-1 activity
toattenuateglucose stimulated insulin secretion (36) and is
targeted by miR-96 in hepatocellular carcinoma (37).
Insulin secretion
miRNAs might contribute to the defects observed in se-
cretion by regulating components of the vesicle fusion
machinery, such synaptotagmins and Doc2b (38, 39),
which are predicted targets of the DownmiRs miR-31-3p,
miR-378a-3p, miR-184, miR-34b-5p, and miR-670-5p.
Targets of miRNAs that are negatively regulated by
AMPK and that might affect insulin synthesis and exo-
cytosis include tyrosine hydroxylase (Th), a predicted
targetofmiR-335-5p that is required forb-celldevelopment
andpromotes insulin synthesis (40).MAPThas been found
to increase b-cell proliferation at the expense of insulin se-
cretion (41) and is a predicted target of miR-135a-3p and
miR-125b. Moreover, the Akt-targeted Rab GTPase–
activating protein TBC1D4, which regulates IBMX- and
glucose-stimulated insulin secretion by EndoC-bH1 and
MIN6 cells, respectively (42), is a putative target of miR-
135aandmiR-125b.MiR-135aalsohasbinding sites inGcgr
39UTR, whose depletion causes impaired b-cell responses
to glucose andother secretagogues (43). The action of these
miRNAs may therefore contribute to the defects in insulin
secretion observed in bAMPKdKO animals (6).
Role of miR-184 in AMPK function
The function of miR-184 in the b cell has been intensively
studied by Tattikota et al. (17). These researchers first
overexpressed this miRNA in MIN6 cells and identified
several down-regulated genes, including Ago2, at the
RNA and protein level. Ago2 is an important component
of miRISC, which is necessary to mediate miRNA-
dependent repression. Tattikota et al. (17) subsequently
generated a constitutive miR-184 knockout model in
which Ago2 expression was slightly but significantly
increased and which presented with reduced fasted
glucose but increased plasma insulin levels and b-cell
mass. Conversely, the researchers overexpressed miR-184
specifically in b cells, and this resulted in reduced Ago2
expression. In contrast, overexpression of Ago2 in the
presence of miR-184 restored normal glucose control (17).
Tattikota et al. (17) concluded that a decrease in miR-184
expression was required for compensatory b-cell pro-
liferation throughup-regulationofAgo2,whereas the effect
Figure 4. miR-184 expression is sex dependent. miRNA ex-
pression was assessed by RT-qPCR in isolated islets from male (M)
and female (F) control mice (A), human islets from male and
female donors (B), human islets from healthy donors and donors
with T2D (C), and human islets from healthy male and female
donors and male and female donors with T2D (D). Each dot
represents islets from a single mouse (A) or human donor (B–D).
Data are expressed as relative to the endogenous control let-7d-3p.
ns, not signiﬁcant. ***P , 0.001 (Student’s t test).
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ofmiR-184on insulin secretionmight bemediatedbyother
targets, such as the mitochondrial glutamate transporter
Slc25a22,whichhasbeenproposed toplayapositive role in
glucose-stimulated insulin secretion (44).
Neither bAMPKdKO nor bLKB1KO islets display
changes in Ago2 expression, as determined by our pre-
viously published RNA sequencing data (6) and further
validated at the RNA level in .6 animals by RT-qPCR
and at the protein level byWestern blot (data not shown).
This is consistent with the opposite effects in b-cell mass
in our bAMPKdKO animals vs. the miR-184 knockouts
generated by Tattikota (17). The mouse and human Ago2
39UTRs are exceptionally long (.11 kb) and therefore
contain binding sites for multiple miRNAs. These include
four of those most up-regulated in bAMPKdKO islets:
miR-135a, miR-125b, miR-100, and miR-99a, with the last
two being experimentally validated in other cell types (45,
46). These up-regulated miRNAs might compensate for
the lack of miR-184 in the absence of AMPK, avoiding a
dynamic and energy-dependent sensor affecting the ex-
pression of such a pleotropic protein as AGO2.
On the other hand, bAMPKdKO islets displayed a
significant increase in Slc25a22 expression vs. controls.
Thus, miR-184 could, through this target, contribute to the
increased insulin secretionobserved in isolatedbAMPKdKO
islets. Interestingly, Slc25a22 has previously been pro-
posed to mediate miR-184 effects in mitochondria mor-
phology and number (18).
Role of AMPK in the regulation of
miR-184 expression
miR-184 is strongly down-regulated in islets from pre-
diabetic and diabetic db/db and ob/obmice and mice fed a
high-fat diet (14, 17). A negative correlation has also been
observed between the expression of this miRNA and the
insulin secretion index of human islets (47). In subsequent
Figure 5. AMPK mediates glucose-dependent regulation of miR-184. miRNA expression was assessed by RT-qPCR in isolated islets from
bAMPKdKO (green) and control (C, black) male (left side) and female (right side) mice cultured with 5.5 or 25 mM glucose for 48 h
(A); male and female human donors cultured with 3, 5.5, or 11 mM glucose for 48 h (B); and bAMPKdKO (green), bLKB1KO (blue),
and control (C, black) male and female mice fed chow (Ch) or a ketogenic (K) diet for 28 d (C). Ns, not signiﬁcant. *P, 0.05, **P,
0.01, ****P , 0.0001 [Student’s t test (A, C) or 2-way repeated-measures ANOVA and Fisher least signiﬁcance difference test (B)].
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studies, Tattikota et al. (18) reported that miR-184 is regu-
lated by glucose in mice and inDrosophila melanogaster. In
vivo, both a ketogenic diet (with virtually no calories de-
riving from carbohydrates) or starvation for 25–30 h
resulted in islet miR-184 up-regulation. Nevertheless,
none of these studies investigated the mechanisms un-
derlying the regulation of this miRNA.
We demonstrate here that depletion of AMPK selec-
tively from the b cell strongly impairs miR-184 expression
and that this also occurs after depletion of the AMPK up-
streamkinaseLKB1.Moreover, a forced increase inAMPK
activity resulted inmiR-184 up-regulation in amurine cell
line (MIN6), inmouse islets (AMPKg2 animals), and,most
importantly, in human islets.
miR-184 is differentially expressed according to sex
The current study revealed that miR-184 is differentially
expressed in islets from male vs. female mice, with a sim-
ilar strong tendency (P = 0.056) observed in human islets.
Sexual dimorphism in the expression of miR-184 has also
previously been observed in ticks (Rhipicephalus haema-
physaloides) (48) and Drosophila (49).
The studies described in refs 17, 18 were apparently
done using mice of the same sex and human islets from
both male and female donors, which might have masked
the existence of sexual dimorphism in the expression of
miR-184. Conversely, this sexual dimorphism may ex-
plain, at least in part, the discrepancies between our study
and that of Tattikota et al. (17), who reported lower miR-
184 expression in T2D islets vs. subjects without diabetes.
Even though our study is limited in this regard by the low
number of T2D samples, two additional independent
studies (50, 51) found no differences in the levels of miR-
184 in diabetic vs. nondiabetic islets. Further study is
needed to reinforce the findings reported here.
In general, the incidence of T2D is similar in men and
women, although differences in glucose metabolism and
insulin action have been previously described. A strong
gender bias has also been observed in animal models of
T2D (52). Any role that the pancreaticb cell plays in sexual
dimorphism is unknown. Recently, Hall et al. (53) found
sex-dependent differences in the DNA methylation pat-
tern in the X-chromosome and in CpG sites of autosomal
chromosomes in human islets. Even though the b-cell
number was identical between male and female subjects,
female islets displayed higher insulin secretion (stimula-
tion index). Changes inDNAmethylationwere associated
with differences in the expression of certain miRNAs and
protein-coding genes, such asNKAP, which inhibits GSIS
through NF-kB activation and 10 genes associated with
T2D by genome-wide association studies. Nevertheless,
neither the methylation status of the miR-184 promoter
nor the expression levels of this miRNA was evaluated.
AMPK was previously reported to show a sex bias in
terms of its activation in response to metabolic stimuli in
liver and adipose tissue, where estrogens affect lipid ac-
cumulation by activating AMPK (54). Sex-biased AMPK
activation, which may contribute to differential miR-184
expression in islets, has not previously been described.
Providing a possible mechanistic underpinning of this
observation, 17b-estradiol transiently stimulates b-cell
AMPK phosphorylation to an extent close to that seen in
response to low glucose (55). Another exciting hypothesis
is the existence of a regulatory serotonin–AMPK–miR-184
Figure 6. AMPK may mediate miR-184 expression at the transcriptional level. A) Pri-miR-184 expression was measured by RT-
qPCR in isolated islets from bAMPKdKO (green) and littermate control (C, black) mice. B) Integration of ATAC-seq enrichment
proﬁles with ENCODE CTCF and transcription factors ChIP-seq datasets. Sequencing tracks for the ;100-kb genomic region
upstream miR-184 show 2 enriched ATAC-seq peaks (red arrows) in bLKB1KO (green) vs. control (black) islets. CTCF ChIP-seq
proﬁles in liver show enrichment of this factor within the most proximal ATAC-seq differential peak. Binding enrichment of
other transcriptional regulators (CH12 cells) is observed at both differential ATAC-seq peaks. Alignment with the human DNA
track is presented in blue.
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pathway. Thus, in Caenorhabditis elegans, AMPK links se-
rotonergic signaling with glutamate release (56), whereas
in the Aplysia nervous system serotonin down-regulates
miR-184 (57). Expression of serotonin receptors and se-
rotonin synthesismay also differ according to sex (58) and
are enhanced in islets during pregnancy (59).
Role of AMPK in regulation of miR-184 by glucose
We demonstrate that AMPK is required for the glucose-
mediated regulation of murine miR-184 expression be-
cause culturing islets at different glucose concentrations or
feeding themice a ketogenic diet had no effect onmiR-184
expression in the absence of AMPK. Feeding a ketogenic
diet has been demonstrated to increase AMPK activity in
liver and muscle (60). In our study, miR-184 expression
remained unchanged after 16 h without food, in contrast
with results obtained byTattikota et al. (18). Themice used
by Tattikota et al. (18) had the same genetic background as
those used in this study but were starved for a longer
period (30 h).
Paradoxically, culture of human islets at different glu-
cose concentrations exerted opposing effects on miR-184
according to sex. Increasing glucose concentrations re-
duced miR-184 in male human islets [as observed in both
male and female mice islets (Fig. 5B)]. The same treatment
increased the expression of the miRNA in female islets,
whereas AMPK activity was increased in both male and
female islets (Supplemental Fig. 2). The underlying causes
of these differences remain to be studied.
Althoughwe have not studied the role of AMPK in the
control of miR-184 in animals maintained on a high-fat
diet, AMPK phosphorylation is greatly reduced in islets
from db/db mice at low glucose concentration vs. control
(db/+) mice (61) as well as in those from diet-induced
obesity (62). We therefore hypothesize that AMPK might
underlie the changes in miR-184—and perhaps other
miRNAs—expression observed by Nesca et al. (14) and
Tattikota et al. (17).
While the present manuscript was under revision,
Gendron and Pletcher (63) reported that miR-184 was
subject to dietary control and contributed to longevity in
Drosophila. It is therefore tempting to speculate that this
miRNA may contribute to the previously elucidated role
of AMPK (64) in controlling lifespan in this species.
Regulation of miR-184 transcription
Our data suggest that the action of AMPK on miR-184
occurs at the transcriptional level. Correspondingly, our
unpublished ATAC-seq data demonstrate a significant
increase in chromatin accessibility in bLKB1KO islets in 2
regions located;25 and;72 kb upstreammiR-184. Data
from ENCODE suggest that CTCF can bind to the proxi-
mal region, whereas MeCP2 binding has been mapped to
the most distal location (28), which could contribute to
repression of miR-184 in bLKB1 islets. In mouse brain,
MeCP2 remains bound to thematernalmiR-184 allele (28),
possibly contributing to the imprinting of miR-184 in this
tissue,which remains to be studied in islets. Future studies
will aimtovalidate these interactions inmouseandhuman
islets and to determine if or how AMPK and LKB1 affect
the activity of these transcriptional regulators.
CONCLUSIONS
Ourwork identifiedanupstreamregulatorofmiR-184and
provided a mechanistic link between altered substrate
metabolism and the expression of any miRNA in b cells.
We thus describe a novel signal transduction pathway
whereby glucose, acting via AMPK, controls the expres-
sion of a critical noncodingRNAand, consequently, genes
involved in b-cell identity and function. Dysregulation
of this pathway by hyperglycemia or other metabolic
changesmay thus contribute to thedevelopment of T2D in
susceptible subjects.
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